Hyliion (NYSE:HYLN) Upgraded to “Hold” at Northland Capmk

Hyliion (NYSE:HYLN) was upgraded by research analysts at Northland Capmk to a “hold” rating in a report released on Tuesday, Zacks.com reports.

Separately, Northland Securities increased their price objective on Hyliion from $1.50 to $2.00 and gave the stock a “market perform” rating in a research report on Tuesday, August 13th.

Hyliion Stock Performance

Shares of Hyliion stock opened at $2.27 on Tuesday. The company has a market cap of $393.16 million, a P/E ratio of -3.71 and a beta of 1.89. The firm has a fifty day moving average of $2.02 and a two-hundred day moving average of $1.74. Hyliion has a one year low of $0.52 and a one year high of $2.73.

Hyliion (NYSE:HYLN) last announced its quarterly earnings data on Tuesday, August 6th. The company reported ($0.06) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.02. As a group, equities analysts predict that Hyliion will post -0.29 earnings per share for the current year.

Insider Transactions at Hyliion

In other news, insider Govindaraj Ramasamy acquired 30,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 11th. The stock was purchased at an average cost of $1.92 per share, with a total value of $57,600.00. Following the purchase, the insider now directly owns 298,000 shares of the company’s stock, valued at approximately $572,160. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 20.40% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the company. HITE Hedge Asset Management LLC acquired a new stake in Hyliion in the 2nd quarter valued at about $656,000. Bank of New York Mellon Corp lifted its holdings in shares of Hyliion by 9.9% in the second quarter. Bank of New York Mellon Corp now owns 574,988 shares of the company’s stock valued at $931,000 after purchasing an additional 51,794 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Hyliion by 11.7% in the first quarter. Vanguard Group Inc. now owns 7,291,480 shares of the company’s stock valued at $12,833,000 after purchasing an additional 762,909 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of Hyliion by 9.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 104,086 shares of the company’s stock worth $184,000 after purchasing an additional 8,580 shares in the last quarter. Finally, The Manufacturers Life Insurance Company raised its position in shares of Hyliion by 20.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 58,072 shares of the company’s stock worth $94,000 after purchasing an additional 9,948 shares during the last quarter. Hedge funds and other institutional investors own 22.81% of the company’s stock.

Hyliion Company Profile